Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.14 0.0400 +40.00%
TLOG $2.71 0.3600 +15.32%
EXEL $6.62 0.5000 +8.17%
INCY $109.74 5.7600 +5.54%
REGN $580.94 26.6700 +4.81%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

NYMX $2.38 -0.1800 -7.03%
GALT $2.65 -0.1300 -4.68%
CTIX $2.41 -0.1000 -3.98%
ONCS $5.79 -0.1900 -3.18%
ADXS $15.35 -0.5000 -3.15%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Yale Study Identifies ‘Major Player’ In Skin Cancer Genes

(Yale News) July 27, 2015 - A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies.
read article 

Antibiotics for H pylori May Prevent Gastric Cancer

(Medscape Medical News) July 24, 2015 - Eliminating the bacterium Helicobacter pylori can reduce the risk for gastric cancer in healthy individuals, according to a systematic review of six trials published online July 22 in the Cochrane Database of Systematic Reviews.
read article (free registration required) 

Many Young Cancer Patients May Have Limited Awareness of Fertility Preservation Options

(Wiley) July 27, 2015 - A new study points to the need for increased awareness of fertility preservation options for young patients with cancer.
read corporate press release 

Understanding Why Some Latina Women Discontinue Participation in Cancer Prevention Outreach

(RPCI) July 24, 2015 - A study led by researchers at Roswell Park Cancer Institute (RPCI) found that age and fear of cancer diagnosis are among the reasons why Latina women do not continue participation following breast and cervical cancer education programs.
read press release 

Vulnerable Populations Often Miss Cancer Warning Signs

(Reuters Health) July 24, 2015 - Some of society’s most vulnerable citizens are also most likely to overlook cancer warning signs, a new U.K. study suggests.
read article 

AstraZeneca Sells Rare Cancer Drug To Sanofi For Up To $300 Million

(Reuters) July 27, 2015 - AstraZeneca, under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi as it continues a drive to raise cash by divesting certain assets.
read article 

FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma

(CNN Money) July 24, 2015 - Amgen today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Kyprolis® (carfilzomib) for Injection in combination with Revlimid® (lenalidomide) and dexamethasone (KRd) for the treatment of patients with multiple myeloma who have received one to three prior lines of therapy.
read article 

Sugary Sodas and Cereals May Get a New FDA Nutrition Label

(Bloomberg) July 24, 2015 - Cereal boxes, soda bottles and other packaged foods in the U.S. could soon include labels explaining how their sugar content measures up against the recommended daily limit.
read article 

World's First Malaria Vaccine Wins CHMP Favour

(PharmaTimes [UK]) July 24, 2015 - GlaxoSmithKline's malaria candidate vaccine Mosquirix, which has been nearly 30 years in the making, has won a positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa.
read article 

Sanofi's Big New Cholesterol Drug Wins European Green Light

(Reuters) July 24, 2015 - A new type of cholesterol drug from Sanofi and Regeneron Pharmaceuticals won a green light from European regulators on Friday, two months behind a rival product from Amgen.
read article 

Bristol-Myers Revenue Boosted by Cancer Drug Opdivo

(Wall Street Journal) July 23, 2015 - Bristol-Myers Squibb Co. said Thursday its second-quarter revenue rose 7% thanks to a boost from sales of its new Opdivo cancer drug, results indicating the company's big bet on such immunotherapies is paying off.
read article (paid subscription required) 

U.S. Could Save up to $16B if Medicare Part D Prices are Negotiated: Paper

(Wall Street Journal/Pharmalot blog) July 23, 2015 - In the latest bid to alter the prescription-drug pricing landscape in the U.S., a new paper argues that the federal government could save between $15.2 billion and $16 billion annually if it negotiated with drug makers for Medicare Part D medicines and obtained the same prices that are paid by Medicaid or the Veterans Health Administration.
read article (paid subscription required) 

Anthem To Buy Cigna, Creating Largest Health Insurer By Enrollment

(NPR/The Two-Way) July 24, 2015 - Health insurer Anthem has struck a deal to acquire rival Cigna for $48 billion — a buyout that would create the country's largest health insurer by enrollment.
read article 

Novartis Drug Revolade® Recommended by CHMP for EU approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder

(MarketWatch) July 24, 2015 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Revolade® (eltrombopag) for the treatment of adult patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST) and are not eligible to receive a hematopoietic stem cell transplant.
read article 

FDA Approves New Treatment for Most Common Form of Advanced Skin Cancer

( July 24, 2015 - The U.S. Food and Drug Administration today approved Odomzo (sonidegib) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy.
read press release 

CancerLinQ™ Patient Advisory Committee Member Highlights Benefit to Cancer Patients

(ASCO in Action) July 23, 2015 - In the most recent edition of The ASCO Post, CancerLinQ Patient Advisory Committee Member Jim Omel, MD shares the many ways CancerLinQ™ strives to benefit people living with cancer. Dr. Omel highlights the committee's commitment to meeting the needs of patients.
read article 

U.S. Rep. Michael Burgess Blames Doctors, Not FDA, for Medical Device's Danger

(Dallas Observer) July 23, 2015 - Congressman Michael Burgess, representing Denton and Tarrant Counties, is a former gynecologist, but that won't stop him from defending a medical device that's been known to spread cancer in women.
read article 

Molecular Partners Confirms Its Focus on Proprietary Oncology Pipeline – Discovery Alliance with Roche Discontinued

(Molecular Partners) July 24, 2015 - Molecular Partners AG today reiterated its commitment to its un-partnered pipeline. This includes advancing the clinical and preclinical development pipeline and ramping up the activities in immuno-oncology.
read corporate press release 

Eisai Says New Cancer Drug Reaching Patients Faster Than Planned

(Bloomberg) July 23, 2014 - Eisai Co. said its new thyroid cancer drug is reaching patients faster than originally planned, months after regulators in its two biggest markets approved the treatment.
read article 

AstraZeneca Chases Biosimilar Avastin Drug with Japanese Group

(Reuters) July 24, 2015 - AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin.
read article 

Focusing on Only 1% of Spending Will Not Solve Nation's Health Care Challenges

(PhRMA/The Catalyst blog) July 23, 2015 - The article ignores the fact that cancer medicines represent only one-fifth of total spending on cancer treatment.
read article 

Rising Cancer Costs Pit Doctors Against Drugmakers

(CBS Moneywatch) July 24, 2015 - Spending on cancer drugs is skyrocketing and shows no signs of slowing.
read article 

Web App Helps Researchers Explore Cancer Genetics

(Brown University) July 23, 2015 - Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
read article 

Bavarian Nordic Announces Initiation of NCI-sponsored Phase 2 Study of PROSTVAC in Patients with Localized Prostate Cancer

(Bavarian Nordic) July 24, 2015 - Bavarian Nordic A/S announced today that the first patient has been enrolled in a new phase 2 clinical study of PROSTVAC, the Company's active prostate cancer immunotherapy candidate.
read corporate press release 

For Prostate Cancer Patients, Risk-Specific Therapies Now More the Norm

(UCSF) July 23, 2015 - After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
read article